Business Wire3d
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
bjo.bmj5d
High-sensitivity C-reactive protein and risk of retinal artery occlusion and ischaemic stroke: a cross-cohort study
Aims Previous studies have suggested an association between retinal artery occlusion (RAO) and ischaemic stroke (IS), both associated with elevated inflammatory factors. However, the role of ...
Healio7d
Retina360: Advances in the Treatment of Geographic Atrophy and Retinal Vein Occlusion
They also will evaluate advances in imaging and current and emerging therapies for the treatment and management of retinal vein occlusion. Upon successful completion of this educational activity ...
Medscape14d
LV Lead Fixation in a Coronary Vein May Be the Cause and Result of Thrombosis
into the coronary sinus to visualize the anatomy and eventually to reveal the cause of the obstruction. The coronary venogram showed total occlusion of the posterolateral vein due to thrombosis ...
Pharmabiz18d
Health Canada authorizes Roche’s Vabysmo pre-filled syringe for three leading causes of vision loss
Mississauga, Ontario Tuesday, January 21, 2025, 14:00 Hrs [IST] ...
ahajournals.org24d
Abstract 180: Acute Encephalopathy : A Presentation To Be Aware of During Stroke Alerts
Its occlusion causes ischemia in the bilateral paramedian thalami with variable midbrain involvement. The frequency of strokes due to AOP occlusion ranges from 0.1‐2% of all ischemic strokes. While ...
Indiatimes25d
Shape & size of retina veins can predict stroke risk: Study
A new study published in the Heart journal reveals that the shape and size of veins and arteries on the ... Examining the retinal vascular network can indicate potential brain blood vessel damage.